Novartis executive sold shares before drug data manipulation made public

August 18, 2019 by  
Filed under News

An unnamed Novartis executive sold 925,400 Swiss francs ($946,000) worth of shares less than three weeks before the U.S. Food and Drug Administration (FDA) announced data from tests of its gene therapy Zolgensma had been manipulated.

Source: Reuters Business News

Comments are closed.